ADVANCED UNRESECTABLE OR METASTATIC BREAST CANCER
Clinical trials for ADVANCED UNRESECTABLE OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED UNRESECTABLE OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED UNRESECTABLE OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to tackle Hard-to-Treat breast cancer
Disease control Recruiting nowThis study tests an experimental drug called HRS-6209 in combination with several other breast cancer treatments (fulvestrant, letrozole, HRS-8080, or HRS-1358) for people with advanced breast cancer that cannot be surgically removed or has spread. The trial includes two stages: …
Matched conditions: ADVANCED UNRESECTABLE OR METASTATIC BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New cocktail of cancer drugs aims to shrink tumors in advanced breast cancer
Disease control Recruiting nowThis study tests several experimental drug combinations (HRS-2189, Fluvastatin, HRS-6209, HRS-8080, HRS-1358) in 300 people with advanced breast cancer that cannot be removed by surgery or has spread. The main goals are to check safety, find the best doses, and see if tumors shri…
Matched conditions: ADVANCED UNRESECTABLE OR METASTATIC BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC